Literature DB >> 20370637

The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.

Sally Pias1, Tabitha A Peterson, Dennis L Johnson, Barbara A Lyons.   

Abstract

Grb7 is a multidomain intracellular signaling protein that links activated tyrosine kinases with downstream signaling targets. Best known for its regulatory role in cell migration and tumor metastasis, Grb7 also regulates inflammation by coupling NF-kappaB-inducing kinase with erbB/EGFR family receptors. The "adaptor" role of Grb7 in these processes depends upon binding to membrane-associated tyrosine kinases through its C-terminal SH2 domain. The Grb7-SH2 domain shares structural and functional similarity with the SH2 domain of Grb2, a constituent of the MAP kinase pathway. Both domains show unusual affinity for cyclic (beta-turn) ligands. The Grb2-SH2 domain also shows distinctive self-association behavior, forming intertwined ("swapped") dimers. While Grb7 and its SH2 domain are each known to dimerize, the mechanisms and functional significance of this self-association are incompletely understood. Additional residues in the Grb7-SH2 domain effectively lengthen its "EF loop" and render the domain a good candidate for swapped dimerization, through exchange of a C-terminal helix. We propose the existence of a swapped dimeric form of the Grb7-SH2 domain and offer a structural model derived through novel application of nuclear magnetic resonance-derived restraints.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370637      PMCID: PMC3758479          DOI: 10.1615/critrevimmunol.v30.i3.70

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  31 in total

1.  Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex.

Authors:  N Schiering; E Casale; P Caccia; P Giordano; C Battistini
Journal:  Biochemistry       Date:  2000-11-07       Impact factor: 3.162

2.  Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Authors:  Pierre Nioche; Wang-Qing Liu; Isabelle Broutin; Franck Charbonnier; Marie-Thérèse Latreille; Michel Vidal; Bernard Roques; Christiane Garbay; Arnaud Ducruix
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

Review 3.  The unfolding story of three-dimensional domain swapping.

Authors:  Frederic Rousseau; Joost W H Schymkowitz; Laura S Itzhaki
Journal:  Structure       Date:  2003-03       Impact factor: 5.006

Review 4.  Grb7 in intracellular signaling and its role in cell regulation.

Authors:  Tang-Long Shen; Jun-Lin Guan
Journal:  Front Biosci       Date:  2004-01-01

5.  Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.

Authors:  Stephanie C Pero; Lyn Oligino; Roger J Daly; Amy L Soden; Chen Liu; Peter P Roller; Peng Li; David N Krag
Journal:  J Biol Chem       Date:  2002-01-24       Impact factor: 5.157

6.  Mechanism and energy landscape of domain swapping in the B1 domain of protein G.

Authors:  Anatoly Malevanets; Fernanda L Sirota; Shoshana J Wodak
Journal:  J Mol Biol       Date:  2008-06-17       Impact factor: 5.469

7.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

8.  Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma.

Authors:  Axel Walch; Katja Specht; Herbert Braselmann; Hubert Stein; Jörg Rüdiger Siewert; Ulrich Hopt; Heinz Höfler; Martin Werner
Journal:  Int J Cancer       Date:  2004-12-10       Impact factor: 7.396

9.  NIK is a component of the EGF/heregulin receptor signaling complexes.

Authors:  Danying Chen; Liang-Guo Xu; Lei Chen; Lixia Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Oncogene       Date:  2003-07-10       Impact factor: 9.867

10.  Systematic identification of regulatory proteins critical for T-cell activation.

Authors:  Peter Chu; Jorge Pardo; Haoran Zhao; Connie C Li; Erlina Pali; Mary M Shen; Kunbin Qu; Simon X Yu; Betty Cb Huang; Peiwen Yu; Esteban S Masuda; Susan M Molineaux; Frank Kolbinger; Gregorio Aversa; Jan de Vries; Donald G Payan; X Charlene Liao
Journal:  J Biol       Date:  2003-09-15
View more
  5 in total

1.  Dimerization in the Grb7 protein.

Authors:  Tabitha A Peterson; Renee L Benallie; Andrew M Bradford; Sally C Pias; Jaron Yazzie; Siamee N Lor; Zachary M Haulsee; Chad K Park; Dennis L Johnson; Larry R Rohrschneider; Anne Spuches; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2012-08       Impact factor: 2.137

2.  Binding and function of phosphotyrosines of the Ephrin A2 (EphA2) receptor using synthetic sterile α motif (SAM) domains.

Authors:  Susmita Borthakur; HyeongJu Lee; SoonJeung Kim; Bing-Cheng Wang; Matthias Buck
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

3.  Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand.

Authors:  Dan Zhang; Chen Shao; Siqi Hu; Sucan Ma; Youhe Gao
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

4.  Oncogenic Mutations Differentially Affect Bax Monomer, Dimer, and Oligomeric Pore Formation in the Membrane.

Authors:  Mingzhen Zhang; Jie Zheng; Ruth Nussinov; Buyong Ma
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379

5.  Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate.

Authors:  Juan Alcalde; María González-Muñoz; Antonio Villalobo
Journal:  Heliyon       Date:  2020-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.